Citigroup (NYSE:C) Chief Financial Officer Gonzalo Luchetti said the bank expects full-year return on tangible common equity, or ROTCE, to finish slightly above the high end of its previously stated 10% to 11% range, citing continued momentum across its markets, banking, services and consumer busine
Kestra Medical Technologies (NASDAQ:KMTS) reported first-quarter fiscal 2027 revenue of $31 million, with President and Chief Executive Officer Brian Webster saying revenue rose 60% from a year earlier and advanced sequentially from the fourth quarter. The company raised its full-year revenue outloo
Radiant Logistics (NYSEAMERICAN:RLGT) reported higher fourth-quarter revenue, profit and adjusted EBITDA for the fiscal quarter ended June 30, 2026, as its U.S. forwarding operations, domestic services and international air freight business contributed to growth.
Net income attributable to Radiant
Evertz Technologies (TSE:ET) reported fiscal 2027 first-quarter revenue of CAD 118.3 million, up 5.5% from CAD 112.0 million a year earlier, as growth in software and services and international sales offset a slight decline in hardware revenue.
For the quarter ended July 31, 2026, the company recor
American Battery Technology (NASDAQ:ABAT) reported a more than 400% increase in fiscal 2026 revenue to $21.7 million, driven by higher throughput at its first lithium-ion battery recycling facility, expanded byproduct manufacturing and improved product pricing, Chief Executive Officer and Chief Tech
MindWalk (NASDAQ:HYFT) reported first-quarter fiscal 2027 revenue of CAD 3.8 million, up 21% from CAD 3.2 million a year earlier, as the company continued investing in commercialization of its ReefIQ biological-data platform and expanded its drug discovery partnership model.
Gross margin increased
On Sept. 14, 2026, CEO Brian Moynihan flagged weaker trading performance and softer dealmaking fees, keeping investors focused on capital-markets sensitivity.
Merck & Co., Inc. (NYSE:MRK) Chairman and CEO Rob Davis said the company’s “transformation is underway,” citing progress across product launches, clinical data readouts, business development and its Animal Health segment during a Morgan Stanley discussion.
Davis said recent pipeline readouts ha
